Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. M. Alvarez Dobaño, E. San Jose, F. J. Gonzalez Barcala, A. Golpe, P. Penela, J. M. Valle, C. Rodriguez Garcia, J. Ricoy, M. E. Toubes, L. Valdes (Santiago de Compostela, Spain). Diagnostic value of N-terminal pro-brain natriuretic peptide levels in pleural effusions of cardiac origin. Eur Respir J 2010; 36: Suppl. 54, 3690

Member's Comments

No comment yet.

Related content which might interest you: Clinical utility of pleural fluid NT-pro-brain natriuretic peptide (NT-proBNP) in patients with pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 580s Year: 2006 Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism Source: Eur Respir J 2014; 43: 1669-1677 Year: 2014 Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions Source: Eur Respir J 2006; 28: 144-150 Year: 2006 The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Serum and pleural albumin gradient and brain natriuretic peptide (BNP) levels in the diagnosis of cardiac and non-cardiac pleural effusions Source: Annual Congress 2008 - Pleural effusion Year: 2008 Prognostic significance of amino-terminal pro-brain natriuretic peptide testing among waitlisted lung transplant candidates Source: Virtual Congress 2021 – Challenging problems in lung transplantation Year: 2021 Plasma n-terminal pro-brain natriuretic peptide (NT pro-BNP) level in respiratory diseases Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 Usefulness of serum (S) and pleural fluid (PF) levels of pro-brain natriuretic peptide (Pro-BNP) in the diagnosis of pleural transudates due to congestive heart failure (CHF) Source: Eur Respir J 2006; 28: Suppl. 50, 581s Year: 2006 Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 The role of pro-brain natriuretic peptide and C-reactive protein as prognostic markers in stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003 Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010 Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases Year: 2007 Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP Source: Eur Respir J 2011; 37: 595-603 Year: 2011 Diagnostic value of NT-proBNP levels in differentiation of cardiac origin of pleural effusions Source: Annual Congress 2008 - Pleural effusion Year: 2008 Utility of N-terminal pro b-type natriuretic peptide (NT-PROBNP) dosage in differential diagnosis of acute dyspnoea Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020 Year: 2020